SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Acadia Healthcare Company, Inc. – ‘10-Q’ for 3/31/18 – ‘EX-10.3’

On:  Thursday, 5/3/18, at 4:07pm ET   ·   For:  3/31/18   ·   Accession #:  1193125-18-150794   ·   File #:  1-35331

Previous ‘10-Q’:  ‘10-Q’ on 10/25/17 for 9/30/17   ·   Next:  ‘10-Q’ on 7/31/18 for 6/30/18   ·   Latest:  ‘10-Q’ on 5/2/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/03/18  Acadia Healthcare Company, Inc.   10-Q        3/31/18  100:7.2M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    593K 
 2: EX-10.3     Material Contract                                   HTML     51K 
 3: EX-10.4     Material Contract                                   HTML     58K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     35K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     35K 
 6: EX-32       Certification -- §906 - SOA'02                      HTML     31K 
13: R1          Document and Entity Information                     HTML     50K 
14: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    114K 
15: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     45K 
                (Parenthetical)                                                  
16: R4          Condensed Consolidated Statements of Income         HTML     92K 
                (Unaudited)                                                      
17: R5          Condensed Consolidated Statements of Income         HTML     32K 
                (Unaudited) (Parenthetical)                                      
18: R6          Condensed Consolidated Statements of Comprehensive  HTML     53K 
                Income (Unaudited)                                               
19: R7          Condensed Consolidated Statements of Comprehensive  HTML     33K 
                Income (Unaudited) (Parenthetical)                               
20: R8          Condensed Consolidated Statement of Equity          HTML     56K 
                (Unaudited)                                                      
21: R9          Condensed Consolidated Statements of Cash Flows     HTML    107K 
                (Unaudited)                                                      
22: R10         Description of Business and Basis of Presentation   HTML     37K 
23: R11         Recently Issued Accounting Standards                HTML     42K 
24: R12         Revenue                                             HTML     98K 
25: R13         Earnings Per Share                                  HTML     41K 
26: R14         Other Intangible Assets                             HTML     46K 
27: R15         Property and Equipment                              HTML     40K 
28: R16         Long-Term Debt                                      HTML     72K 
29: R17         Equity-Based Compensation                           HTML     82K 
30: R18         Income Taxes                                        HTML     47K 
31: R19         Derivatives                                         HTML     35K 
32: R20         Fair Value Measurements                             HTML     43K 
33: R21         Commitments and Contingencies                       HTML     34K 
34: R22         Noncontrolling Interests                            HTML     37K 
35: R23         Other Current Assets                                HTML     38K 
36: R24         Other Accrued Liabilities                           HTML     38K 
37: R25         Segment Information                                 HTML     62K 
38: R26         Accumulated Other Comprehensive Loss                HTML     39K 
39: R27         Financial Information for the Company and Its       HTML    290K 
                Subsidiaries                                                     
40: R28         Revenue (Tables)                                    HTML     80K 
41: R29         Earnings Per Share (Tables)                         HTML     40K 
42: R30         Other Intangible Assets (Tables)                    HTML     45K 
43: R31         Property and Equipment (Tables)                     HTML     40K 
44: R32         Long-Term Debt (Tables)                             HTML     45K 
45: R33         Equity-Based Compensation (Tables)                  HTML     74K 
46: R34         Fair Value Measurements (Tables)                    HTML     40K 
47: R35         Noncontrolling Interests (Tables)                   HTML     34K 
48: R36         Other Current Assets (Tables)                       HTML     37K 
49: R37         Other Accrued Liabilities (Tables)                  HTML     37K 
50: R38         Segment Information (Tables)                        HTML     64K 
51: R39         Accumulated Other Comprehensive Loss (Tables)       HTML     38K 
52: R40         Financial Information for the Company and Its       HTML    284K 
                Subsidiaries (Tables)                                            
53: R41         Description of Business and Basis of Presentation   HTML     34K 
                - Additional Information (Detail)                                
54: R42         Revenue - Additional Information (Detail)           HTML     38K 
55: R43         Revenue - Summary of Impact of Adoption of          HTML     40K 
                Accounting Standards (Detail)                                    
56: R44         Revenue - Schedule of U.S. Revenue Attributed to    HTML     43K 
                Each Category (Detail)                                           
57: R45         Revenue - Schedule of U.S. Revenue Generated by     HTML     51K 
                Each Payor Type (Detail)                                         
58: R46         Revenue - Schedule of U.K. Revenue Attributed to    HTML     41K 
                Each Category (Detail)                                           
59: R47         Revenue - Schedule of U.K. Revenue Generated by     HTML     46K 
                Each Payor Type (Detail)                                         
60: R48         Revenue - Summary of the Activity in Unearned       HTML     41K 
                Revenue (Detail)                                                 
61: R49         Earnings Per Share - Computation of Basic and       HTML     52K 
                Diluted Earnings Per Share (Detail)                              
62: R50         Earnings Per Share - Additional Information         HTML     32K 
                (Detail)                                                         
63: R51         Other Intangible Assets - Other Identifiable        HTML     56K 
                Intangible Assets and Related Accumulated                        
                Amortization (Detail)                                            
64: R52         Property and Equipment - Summary of Property and    HTML     47K 
                Equipment (Detail)                                               
65: R53         Long-Term Debt - Components of Long-Term Debt       HTML     66K 
                (Detail)                                                         
66: R54         Long-Term Debt - Components of Long-Term Debt       HTML     52K 
                (Parenthetical) (Detail)                                         
67: R55         Long-Term Debt (Amended and Restated Senior Credit  HTML    164K 
                Facility) - Additional Information (Detail)                      
68: R56         Long-Term Debt (6.125% Senior Notes due 2021) -     HTML     41K 
                Additional Information (Detail)                                  
69: R57         Long-Term Debt (5.125% Senior Notes due 2022) -     HTML     41K 
                Additional Information (Detail)                                  
70: R58         Long-Term Debt (5.625% Senior Notes due 2023) -     HTML     41K 
                Additional Information (Detail)                                  
71: R59         Long-Term Debt (6.500% Senior Notes due 2024) -     HTML     41K 
                Additional Information (Detail)                                  
72: R60         Long-Term Debt (9.0% and 9.5% Revenue Bonds) -      HTML     56K 
                Additional Information (Detail)                                  
73: R61         Equity-Based Compensation - Additional Information  HTML     61K 
                (Detail)                                                         
74: R62         Equity-Based Compensation - Stock Option Activity   HTML     76K 
                (Detail)                                                         
75: R63         Equity-Based Compensation - Schedule of Stock       HTML     40K 
                Options Valuation Assumptions (Detail)                           
76: R64         Equity-Based Compensation - Restricted Stock        HTML     53K 
                Activity (Detail)                                                
77: R65         Equity-Based Compensation - Restricted Stock Unit   HTML     53K 
                Activity (Detail)                                                
78: R66         Income Taxes - Additional Information (Detail)      HTML     60K 
79: R67         Derivatives - Additional Information (Detail)       HTML     40K 
80: R68         Fair Value Measurements - Carrying Amounts and      HTML     73K 
                Fair Values of Company's Amended and Restated                    
                Senior Credit Facilities and Contingent                          
                Consideration Liabilities (Detail)                               
81: R69         Fair Value Measurements - Additional Information    HTML     49K 
                (Detail)                                                         
82: R70         Commitments and Contingencies - Additional          HTML     38K 
                Information (Detail)                                             
83: R71         Noncontrolling Interests - Additional Information   HTML     36K 
                (Detail)                                                         
84: R72         Noncontrolling Interests - Summary of Redeemable    HTML     38K 
                Noncontrolling Interests (Detail)                                
85: R73         Other Current Assets - Other Current Assets         HTML     48K 
                (Detail)                                                         
86: R74         Other Accrued Liabilities - Summary of Other        HTML     53K 
                Accrued Liabilities (Detail)                                     
87: R75         Segment Information - Additional Information        HTML     39K 
                (Detail)                                                         
88: R76         Segment Information - Summary of Reconciliation of  HTML     62K 
                Segment EBITDA to Income from Continuing                         
                Operations (Detail)                                              
89: R77         Segment Information - Summary of Financial          HTML     43K 
                Information by Operating Segment, Goodwill                       
                (Detail)                                                         
90: R78         Segment Information - Summary of Financial          HTML     40K 
                Information by Operating Segment, Assets (Detail)                
91: R79         Segment Information - Summary of Financial          HTML     42K 
                Information by Operating Segment, Assets                         
                (Parenthetical) (Detail)                                         
92: R80         Accumulated Other Comprehensive Loss - Components   HTML     52K 
                Of Accumulated Other Comprehensive Loss (Detail)                 
93: R81         Accumulated Other Comprehensive Loss - Components   HTML     33K 
                Of Accumulated Other Comprehensive Loss                          
                (Parenthetical) (Detail)                                         
94: R82         Financial Information for the Company and Its       HTML     44K 
                Subsidiaries - Additional Information (Detail)                   
95: R83         Financial Information for the Company and Its       HTML    137K 
                Subsidiaries - Summary of Condensed Consolidating                
                Balance Sheets (Detail)                                          
96: R84         Financial Information for the Company and Its       HTML    119K 
                Subsidiaries - Summary of Condensed Consolidating                
                Statement of Comprehensive Income (Loss) (Detail)                
97: R85         Financial Information for the Company and Its       HTML    147K 
                Subsidiaries - Summary of Condensed Consolidating                
                Statement of Cash Flows (Detail)                                 
99: XML         IDEA XML File -- Filing Summary                      XML    190K 
98: EXCEL       IDEA Workbook of Financial Reports                  XLSX     96K 
 7: EX-101.INS  XBRL Instance -- achc-20180331                       XML   2.19M 
 9: EX-101.CAL  XBRL Calculations -- achc-20180331_cal               XML    265K 
10: EX-101.DEF  XBRL Definitions -- achc-20180331_def                XML    789K 
11: EX-101.LAB  XBRL Labels -- achc-20180331_lab                     XML   1.21M 
12: EX-101.PRE  XBRL Presentations -- achc-20180331_pre              XML   1.16M 
 8: EX-101.SCH  XBRL Schema -- achc-20180331                         XSD    196K 
100: ZIP         XBRL Zipped Folder -- 0001193125-18-150794-xbrl      Zip    189K  


‘EX-10.3’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-10.3  

Exhibit 10.3

FORM OF RESTRICTED STOCK AGREEMENT

PURSUANT TO THE

ACADIA HEALTHCARE COMPANY, INC.

INCENTIVE COMPENSATION PLAN

* * * * *

Participant:                                                          

Grant Date:                                                            

Number of Shares of Restricted Stock Granted:                         

* * * * *

THIS RESTRICTED STOCK AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Acadia Healthcare Company, Inc., a corporation organized in the State of Delaware (the “Company”), and the Participant specified above, pursuant to the Acadia Healthcare Company, Inc. Incentive Compensation Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and

WHEREAS, it has been determined under the Plan that it would be in the best interests of the Company to grant the shares of Restricted Stock provided herein to the Participant.

NOW, THEREFORE, in consideration of the mutual covenants and promises hereinafter set forth and for other good and valuable consideration, the parties hereto hereby mutually covenant and agree as follows:

1. Incorporation By Reference; Plan Document Receipt. This Agreement is subject in all respects to the terms and provisions of the Plan (including, without limitation, any amendments thereto adopted at any time and from time to time unless such amendments are expressly intended not to apply to the Award provided hereunder), all of which terms and provisions are made a part of and incorporated in this Agreement as if they were each expressly set forth herein. Any capitalized term not defined in this Agreement shall have the same meaning as is ascribed thereto in the Plan. The Participant hereby acknowledges receipt of a true copy of the Plan and that the Participant has read the Plan carefully and fully understands its content.

2. Grant of Restricted Stock Award. The Company hereby grants to the Participant, as of the Grant Date specified above, the number of shares of Restricted Stock specified above. Except as otherwise provided by the Plan, the Participant agrees and understands that nothing contained in this Agreement provides, or is intended to provide, the Participant with any protection against potential future dilution of the Participant’s interest in the Company for any reason, and no adjustments shall be made for dividends in cash or other property, distributions or other rights in respect of any such shares, except as otherwise specifically provided for in the Plan or this Agreement. Subject to Section 5 hereof, the Participant shall not have the rights of a stockholder in respect of the shares underlying this Award until such shares are delivered to the Participant in accordance with Section 4 hereof.


3. Vesting.

(a) Subject to the provisions of Sections 3(b) and 3(c) hereof, the Restricted Stock subject to this grant shall become unrestricted and vested as follows, provided that the Participant has not incurred a Termination prior to each such vesting date:

 

Vesting Date

  

Number of Shares

There shall be no proportionate or partial vesting in the periods prior to each vesting date and all vesting shall occur only on the appropriate vesting date, subject to the Participant’s continued service with the Company or any of its Subsidiaries on each applicable vesting date.

(b) Accelerated Vesting. Notwithstanding the foregoing, the Committee may, in its sole discretion, provide for accelerated vesting of the Restricted Stock at any time and for any reason. In addition, accelerated vesting of the Restricted Stock may be provided for in an employment agreement or other agreement between the Company and the Participant.

(c) Forfeiture. Subject to the Committee’s discretion to accelerate vesting hereunder, all unvested shares of Restricted Stock shall be immediately forfeited upon the Participant’s Termination for any reason.

4. Period of Restriction; Delivery of Unrestricted Shares. During the period from the date hereof until such time as the shares of Restricted Stock awarded by this Agreement become vested, the Restricted Stock shall bear a legend as described in Section 8.2(c) of the Plan. When shares of Restricted Stock awarded by this Agreement become vested, the Participant shall be entitled to receive unrestricted shares and if the Participant’s stock certificates contain legends restricting the transfer of such shares, the Participant shall be entitled to receive new stock certificates free of such legends (except any legends requiring compliance with securities laws).

5. Dividends and Other Distributions; Voting. The Participant shall be entitled to receive all dividends and other distributions paid with respect to the Restricted Stock, provided that any such dividends or other distributions will be subject to the same vesting requirements as the underlying Restricted Stock and shall be paid at the time the Restricted Stock becomes vested pursuant to Section 3 hereof. If any dividends or distributions are paid in shares, the shares shall be deposited with the Company and shall be subject to the same restrictions on transferability and forfeitability as the Restricted Stock with respect to which they were paid. The Participant may exercise full voting rights with respect to the Restricted Stock granted hereunder.

 

2


6. Non-Transferability. The shares of Restricted Stock, and any rights and interests with respect thereto, issued under this Agreement and the Plan shall not, prior to vesting, be sold, exchanged, transferred, assigned or otherwise disposed of in any way by the Participant (or any beneficiary of the Participant), other than by testamentary disposition by the Participant or the laws of descent and distribution. Any attempt to sell, exchange, transfer, assign, pledge, encumber or otherwise dispose of or hypothecate in any way any of the Restricted Stock, or the levy of any execution, attachment or similar legal process upon the Restricted Stock, contrary to the terms and provisions of this Agreement and/or the Plan shall be null and void and without legal force or effect.

7. Governing Law. All questions concerning the construction, validity and interpretation of this Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, without regard to the choice of law principles thereof.

8. Withholding of Tax. The Company shall have the power and the right to deduct or withhold, or require the Participant to remit to the Company, an amount sufficient to satisfy any federal, state, local and foreign taxes of any kind (including, but not limited to, the Participant’s FICA and SDI obligations) which the Company, in its sole discretion, deems necessary to be withheld or remitted to comply with the Code and/or any other applicable law, rule or regulation with respect to the Restricted Stock and, if the Participant fails to do so, the Company may otherwise refuse to issue or transfer any shares of Common Stock otherwise required to be issued pursuant to this Agreement. Any statutorily required withholding obligation with regard to the Participant may be satisfied by reducing the amount of cash or shares of Common Stock otherwise deliverable to the Participant hereunder or by the Participant’s delivery of shares of Common Stock already owned.

9. Section 83(b). If the Participant properly elects (as required by Section 83(b) of the Code) within 30 days after the issuance of the Restricted Stock to include in gross income for federal income tax purposes in the year of issuance the Fair Market Value of such shares of Restricted Stock, the Participant shall pay to the Company or make arrangements satisfactory to the Company to pay to the Company upon such election, any federal, state or local taxes required to be withheld with respect to the Restricted Stock. If the Participant shall fail to make such payment, the Company shall, to the extent permitted by law, have the right to deduct from any payment of any kind otherwise due to the Participant any federal, state or local taxes of any kind required by law to be withheld with respect to the Restricted Stock, as well as the rights set forth in Section 8 hereof. The Participant acknowledges that it is the Participant’s sole responsibility, and not the Company’s, to file timely and properly the election under Section 83(b) of the Code and any corresponding provisions of state tax laws if the Participant elects to make such election, and the Participant agrees to timely provide the Company with a copy of any such election.

10. Legend. All certificates representing the Restricted Stock shall have endorsed thereon the legend set forth in Section 8.2(c) of the Plan. Notwithstanding the foregoing, in no event shall the Company be obligated to deliver to the Participant a certificate representing the Restricted Stock prior to the vesting dates set forth above.

 

3


11. Securities Representations. The shares of Restricted Stock are being issued to the Participant and this Agreement is being made by the Company in reliance upon the following express representations and warranties of the Participant. The Participant acknowledges, represents and warrants that:

(a) The Participant has been advised that the Participant may be an “affiliate” within the meaning of Rule 144 under the Securities Act and in this connection the Company is relying in part on the Participant’s representations set forth in this Section 11.

(b) If the Participant is deemed an affiliate within the meaning of Rule 144 of the Securities Act, the shares of Restricted Stock must be held indefinitely unless an exemption from any applicable resale restrictions is available or the Company files an additional registration statement (or a “re-offer prospectus”) with regard to the shares of Restricted Stock and the Company is under no obligation to register the shares of Restricted Stock (or to file a “re-offer prospectus”).

(c) If the Participant is deemed an affiliate within the meaning of Rule 144 of the Securities Act, the Participant understands that (i) the exemption from registration under Rule 144 will not be available unless (A) a public trading market then exists for the Common Stock of the Company, (B) adequate information concerning the Company is then available to the public, and (C) other terms and conditions of Rule 144 or any exemption therefrom are complied with, and (ii) any sale of the shares of vested Restricted Stock hereunder may be made only in limited amounts in accordance with the terms and conditions of Rule 144 or any exemption therefrom.

12. Entire Agreement; Amendment. This Agreement, together with the Plan, contains the entire agreement between the parties hereto with respect to the subject matter contained herein, and supersedes all prior agreements or prior understandings, whether written or oral, between the parties relating to such subject matter. The Committee shall have the right, in its sole discretion, to modify or amend this Agreement from time to time in accordance with and as provided in the Plan. This Agreement may also be modified or amended by a writing signed by both the Company and the Participant. The Company shall give written notice to the Participant of any such modification or amendment of this Agreement as soon as practicable after the adoption thereof.

13. Notices. Any notice hereunder by the Participant shall be given to the Company in writing and such notice shall be deemed duly given only upon receipt thereof by the General Counsel of the Company. Any notice hereunder by the Company shall be given to the Participant in writing and such notice shall be deemed duly given only upon receipt thereof at such address as the Participant may have on file with the Company.

14. Acceptance. As required by Section 8.2 of the Plan, the Participant shall forfeit the Restricted Stock if the Participant does not execute this Agreement within a period of sixty (60) days from the date that the Participant receives this Agreement (or such other period as the Committee shall provide).

15. No Right to Employment. Any questions as to whether and when there has been a Termination and the cause of such Termination shall be determined in the sole discretion of the Committee. Nothing in this Agreement shall interfere with or limit in any way the right of the Company, its Subsidiaries or Affiliates to terminate the Participant’s employment or service at any time, for any reason and with or without Cause.

 

4


16. Transfer of Personal Data. The Participant authorizes, agrees and unambiguously consents to the transmission by the Company (or any Subsidiary) of any personal data information related to the Restricted Stock awarded under this Agreement for legitimate business purposes (including, without limitation, the administration of the Plan). This authorization and consent is freely given by the Participant.

17. Compliance with Laws. The issuance of the Restricted Stock or unrestricted shares pursuant to this Agreement shall be subject to, and shall comply with, any applicable requirements of any foreign and U.S. federal and state securities laws, rules and regulations (including, without limitation, the provisions of the Securities Act, the Exchange Act and in each case any respective rules and regulations promulgated thereunder) and any other law or regulation applicable thereto. The Company shall not be obligated to issue the Restricted Stock or any of the shares pursuant to this Agreement if any such issuance would violate any such requirements.

18. Section 409A. Notwithstanding anything herein or in the Plan to the contrary, the shares of Restricted Stock are intended to be exempt from the applicable requirements of Section 409A of the Code and shall be limited, construed and interpreted in accordance with such intent.

19. Binding Agreement; Assignment. This Agreement shall inure to the benefit of, be binding upon, and be enforceable by the Company and its successors and assigns. The Participant shall not assign (except in accordance with Section 6 hereof) any part of this Agreement without the prior express written consent of the Company.

20. Headings. The titles and headings of the various sections of this Agreement have been inserted for convenience of reference only and shall not be deemed to be a part of this Agreement.

21. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which shall constitute one and the same instrument.

22. Further Assurances. Each party hereto shall do and perform (or shall cause to be done and performed) all such further acts and shall execute and deliver all such other agreements, certificates, instruments and documents as either party hereto reasonably may request in order to carry out the intent and accomplish the purposes of this Agreement and the Plan and the consummation of the transactions contemplated thereunder.

23. Severability. The invalidity or unenforceability of any provisions of this Agreement in any jurisdiction shall not affect the validity, legality or enforceability of the remainder of this Agreement in such jurisdiction or the validity, legality or enforceability of any provision of this Agreement in any other jurisdiction, it being intended that all rights and obligations of the parties hereunder shall be enforceable to the fullest extent permitted by law.

 

5


24. Acquired Rights. The Participant acknowledges and agrees that: (a) the Company may terminate or amend the Plan at any time; (b) the award of Restricted Stock made under this Agreement is completely independent of any other award or grant and is made at the sole discretion of the Company; (c) no past grants or awards (including, without limitation, the Restricted Stock awarded hereunder) give the Participant any right to any grants or awards in the future whatsoever; and (d) any benefits granted under this Agreement are not part of the Participant’s ordinary salary, and shall not be considered as part of such salary in the event of severance, redundancy or resignation.

* * * * *

 

6


IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of                                         .

 

ACADIA HEALTHCARE COMPANY, INC.
By:     
Name:     
Title:     

 

PARTICIPANT
 

 

Name:     

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Acadia Healthcare Co., Inc.       10-K       12/31/23  128:15M                                    Donnelley … Solutions/FA
 2/28/23  Acadia Healthcare Co., Inc.       10-K       12/31/22  133:18M                                    ActiveDisclosure/FA
 3/01/22  Acadia Healthcare Co., Inc.       10-K       12/31/21  135:19M                                    ActiveDisclosure/FA
 2/26/21  Acadia Healthcare Co., Inc.       10-K       12/31/20  139:21M                                    ActiveDisclosure/FA
Top
Filing Submission 0001193125-18-150794   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 10:53:16.2am ET